US Stock MarketDetailed Quotes
ALLR Allarity Therapeutics
- 1.2500
- +0.0400+3.31%
Close Nov 19 16:00 ET
- 1.2500
- 0.00000.00%
Post 19:02 ET
5.54MMarket Cap-177P/E (TTM)
1.2600High1.1800Low285.01KVolume1.1900Open1.2100Pre Close344.73KTurnover6.43%Turnover Ratio0.00P/E (Static)4.43MShares666.000052wk High0.43P/B5.54MFloat Cap1.150052wk Low--Dividend TTM4.43MShs Float15288000.0000Historical High--Div YieldTTM6.61%Amplitude1.1500Historical Low1.2090Avg Price1Lot Size
Allarity Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -41.03%2.61M | -18.89%3.37M | 15.59%4.24M | 1.40%17.13M | 53.14%4.88M | -2.98%4.43M | -14.17%4.16M | -14.74%3.67M | -36.39%16.89M | -79.76%3.19M |
| Selling and administrative expenses | -35.88%1.59M | -24.19%2.31M | -7.63%2.07M | 0.64%10.03M | 0.49%2.26M | 59.05%2.48M | -3.02%3.05M | -25.62%2.24M | -19.40%9.96M | -63.91%2.25M |
| -General and administrative expense | -35.88%1.59M | -24.19%2.31M | -7.63%2.07M | 0.64%10.03M | 0.49%2.26M | 59.05%2.48M | -3.02%3.05M | -25.62%2.24M | -19.40%9.96M | -63.91%2.25M |
| Research and development costs | -47.59%1.02M | -4.25%1.06M | 52.07%2.17M | 2.50%7.1M | 178.75%2.62M | -35.15%1.95M | -34.85%1.11M | 10.71%1.43M | -51.18%6.93M | -90.12%941K |
| Operating profit | 41.03%-2.61M | 18.89%-3.37M | -15.59%-4.24M | -1.40%-17.13M | -53.14%-4.88M | 2.98%-4.43M | 14.17%-4.16M | 14.74%-3.67M | 36.39%-16.89M | 79.76%-3.19M |
| Net non-operating interest income expense | 1,059.09%211K | -168.35%-373K | -15.91%-102K | -146.63%-476K | -116.19%-227K | -4.76%-22K | -396.43%-139K | -125.64%-88K | 90.29%-193K | 92.26%-105K |
| Non-operating interest income | 2,075.00%261K | 1,666.67%53K | --0 | -26.67%22K | -72.73%3K | -14.29%12K | -40.00%3K | --4K | --30K | --11K |
| Non-operating interest expense | 47.06%50K | 200.00%426K | 10.87%102K | 123.32%498K | 98.28%230K | -2.86%34K | 330.30%142K | 135.90%92K | -65.16%223K | -71.14%116K |
| Other net income (expense) | -956,900.00%-9.57M | 10.44%2.12M | 22.52%495K | 1,271.46%5.79M | 2,211.33%3.47M | 100.22%1K | 936.24%1.92M | 1,088.24%404K | -124.36%-494K | -52.53%150K |
| Gain on sale of security | 13,400.00%135K | 10.44%2.12M | 22.52%495K | -60.38%6.38M | 9.26%4.06M | 100.22%1K | 235.38%1.92M | -96.70%404K | 975.28%16.1M | 2,084.71%3.71M |
| Special income (charges) | ---9.7M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -1,750.85%-16.59M | -844.05%-3.56M |
| -Less:Impairment of capital assets | --9.7M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --17.57M | --3.56M |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --800K | --0 |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 77.11%1.78M | --0 |
| Other non- operating income (expenses) | ---- | ---- | ---- | ---591K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -169.10%-11.97M | 31.55%-1.63M | -14.77%-3.85M | 32.77%-11.82M | 47.82%-1.64M | 11.63%-4.45M | 53.32%-2.38M | 22.17%-3.35M | 33.70%-17.58M | 81.28%-3.14M |
| Income tax | -377K | 0 | -4K | 105.46%83K | 127.39%83K | 0 | 0 | 0 | -1,243.61%-1.52M | -965.71%-303K |
| Net income | -160.63%-11.59M | 31.55%-1.63M | -14.65%-3.84M | 25.89%-11.9M | 39.32%-1.72M | 11.71%-4.45M | 53.36%-2.38M | -8.83%-3.35M | 39.74%-16.06M | 83.12%-2.84M |
| Net income continuous Operations | -160.63%-11.59M | 31.55%-1.63M | -14.65%-3.84M | 25.89%-11.9M | 39.32%-1.72M | 11.71%-4.45M | 53.36%-2.38M | -8.83%-3.35M | 39.74%-16.06M | 83.12%-2.84M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -160.63%-11.59M | 31.55%-1.63M | -14.65%-3.84M | 25.89%-11.9M | 39.32%-1.72M | 11.71%-4.45M | 53.36%-2.38M | -8.83%-3.35M | 39.74%-16.06M | 83.12%-2.84M |
| Preferred stock dividends | -49.14%562K | -99.04%71K | 825.00%37K | 70.54%8.52M | 0 | -32.87%1.11M | 437.84%7.41M | -99.75%4K | 4.99M | 264K |
| Other preferred stock dividends | 0 | -31K | 0 | 0 | ||||||
| Net income attributable to common stockholders | -118.88%-12.15M | 82.95%-1.67M | -15.61%-3.88M | 3.02%-20.42M | 44.49%-1.72M | 16.92%-5.55M | -51.02%-9.79M | 27.86%-3.36M | 21.00%-21.05M | 81.55%-3.1M |
| Basic earnings per share | 99.43%-7.71 | 99.43%-66 | 99.03%-664.2 | 80.64%-6.16K | 96.25%-175.5173 | 91.40%-1.35K | 30.52%-11.66K | -441.79%-68.49K | 59.79%-31.8K | 90.61%-4.69K |
| Diluted earnings per share | 99.43%-7.71 | 99.43%-66 | 99.03%-664.2 | 80.64%-6.16K | 96.25%-175.5173 | 91.40%-1.35K | 30.52%-11.66K | -441.79%-68.49K | 59.79%-31.8K | 90.61%-4.69K |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data